Log in to save to my catalogue

Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic po...

Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic po...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2102924197

Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience

About this item

Full title

Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience

Publisher

New York: Springer US

Journal title

Journal of neuro-oncology, 2018-12, Vol.140 (3), p.629-638

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Background
Diffuse intrinsic pontine glioma (DIPG) is a rare, aggressive brain tumor with no known cure. Reirradiation (reRT) at recurrence can prolong survival. The impact of irradiation may be heightened when combined with PD-1 inhibition. We describe our experience using reRT, with or without PD-1 inhibition, in a cohort of patients with recu...

Alternative Titles

Full title

Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2102924197

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2102924197

Other Identifiers

ISSN

0167-594X

E-ISSN

1573-7373

DOI

10.1007/s11060-018-2991-5

How to access this item